Iganidipine

Modify Date: 2024-01-10 18:36:30

Iganidipine Structure
Iganidipine structure
Common Name Iganidipine
CAS Number 119687-33-1 Molecular Weight 526.62500
Density 1.164g/cm3 Boiling Point 641.5ºC at 760mmHg
Molecular Formula C28H38N4O6 Melting Point N/A
MSDS N/A Flash Point 341.8ºC

 Use of Iganidipine


Iganidipine is a Ca2+ antagonist.

 Names

Name 5-O-[2,2-dimethyl-3-(4-prop-2-enylpiperazin-1-yl)propyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Synonym More Synonyms

 Iganidipine Biological Activity

Description Iganidipine is a Ca2+ antagonist.
Related Catalog
Target

Ca2+[1]

In Vivo Iganidipine (0.03% solution) significantly increases optic nerve head (ONH) tissue blood velocity (NBONH) by 8 to 10% in treated eyes after a single administration (p<0.05) or by 18 to 35% after 7-, 14-, or 21-day twicedaily administration in rabbits (p<0.05). In monkeys, 0.03% and 0.1% Iganidipine significantly increases NBONH in treated eyes by 20 and 41% after 7-day (p<0.05) twice-daily administration, respectively[1].
Animal Admin Monkeys[1] Five adult cynomolgus monkeys (age, 5-8 years; weight, 3-5 kg; sex, 5 males) are used. All examinations are performed with the monkeys sitting in a modified monkey chair. On the first experimental day, after general anesthesia is induced by Ketamine hydrochloride at a dose of 8 to 10 mg/kg intramuscularly, pupil dilation is induced with one drop of Tropicamide in both eyes. The NBONH, IOP, blood pressure, pulse rate, SaO2, and body temperature are measured at 9AM. Starting on the 2nd experimental day, Iganidipine (0.03% or 0.1%, 30 mL) is administered in one randomly chosen eye and vehicle solution into the other eye twice daily at 8AM and 8PM for 7 days. At 9AM on the 8th experimental day, the same measurements are repeated after general anesthesia and bilateral pupil dilation. After a 4-week interval, a second series of experiments is performed using a different Iganidipine concentration according to the same time schedule.
References

[1]. Ishii K, et al. Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation. Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1169-77.

 Chemical & Physical Properties

Density 1.164g/cm3
Boiling Point 641.5ºC at 760mmHg
Molecular Formula C28H38N4O6
Molecular Weight 526.62500
Flash Point 341.8ºC
Exact Mass 526.27900
PSA 116.93000
LogP 4.10340
Vapour Pressure 2.37E-16mmHg at 25°C
Index of Refraction 1.548

 Synonyms

Iganidipine
UNII-9FPE98DLZ5